Profile
ACTU VRTX REGN VRNA ARGX ALNY
Company Name Actuate Therapeutics Inc Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $102.50M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Daniel Schmitt Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ACTU VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
ACTU VRTX REGN VRNA ARGX ALNY
Last Close $5.92 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $11.9 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $5.66 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -50.25 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 4.59 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ACTU VRTX REGN VRNA ARGX ALNY
1 Month Return -20.86 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -28.24 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -43.89 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -21.59 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -25.63 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -33.78 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACTU VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -10208925.5 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ACTU VRTX REGN VRNA ARGX ALNY
Asset Growth 211.07 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -10.54 % 9.09 % -131.37 % 24.59 %
Net Income Growth -10.27 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -4.27 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -4.27 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -4.27 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -0.75 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -1.01 % - -143.33 % -107.98 %
Operating 3 Year CFG 5.43 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 5.43 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 5.43 % -100 % 40.15 % 97.08 %
EPS Growth -97.58 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -97.58 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 100.08 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -99.46 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -99.46 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -99.46 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth - 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -1.01 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ACTU VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -136.16 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -2924.5 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -214.84 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 98.99 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.95 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.95 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 79.11 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM - 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -5.02 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -4.62 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -4.62 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
ACTU VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.03B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.03B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -3.26 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ACTU VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.01B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ACTU VRTX REGN VRNA ARGX ALNY
Net Income $-0.03B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24
AARD Aardvark Therapeutics, Inc. Common Stock 12.61
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.12
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.47
ABPWW 0.0131
ABSI Absci Corporation 2.64
ABUS Arbutus Biopharma Corporation 4.16
ABVC ABVC BioPharma, Inc. 1.7
ABVX Abivax SA American Depositary Shares 119.18
ACAD ACADIA Pharmaceuticals Inc. 22.7
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.13
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.36
ACIU AC Immune SA 3.06
ETFs With Exposure to ACTU
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0 266.16
VTI Vanguard Total Stock Market Index Fund 0.00009 341.8
IWO iShares Russell 2000 Growth ETF 0 341.28
VXF Vanguard Extended Market Index Fund 0.00078 219.45
HDG ProShares Hedge Replication ETF 0.00020575 52.7979
UWM ProShares Ultra Russell2000 0.00111919 54.41
IWC iShares Micro-Cap ETF 0.01 169.95
URTY ProShares UltraPro Russell2000 0.000835371 65.72
SMMD iShares Russell 2500 ETF 0 81.28
VTWG Vanguard Russell 2000 Growth Index Fund 0.00375 249.225
VTWO Vanguard Russell 2000 Index Fund 0.00197 107.59
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 50.34
VUN.TO Vanguard U.S. Total Market Index ETF 0.00008 125.94
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00008 118.65
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00011 115.08
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00011 115.06
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00007 52.59
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00007 52.59
VBINX Vanguard Balanced Index Fund Investor Shares 0.00007 52.59
VGRO.TO Vanguard Growth ETF Portfolio 0.00003 44.3
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00004 55.73
VBAL.TO Vanguard Balanced ETF Portfolio 0.00002 37.81
VCNS.TO Vanguard Conservative ETF Portfolio 0.00002 32.08
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00001 27.325
VRIF.TO Vanguard Retirement Income ETF Portfolio 0.00001 26.945
VTSAX Vanguard Total Stock Market Index Fund 0.00009 166.35
R2US.L SPDR Russell 2000 US Small Cap UCITS ETF 0.00021 78.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00078 166.39
VITSX Vanguard Total Stock Market Index Fund 0.00009 166.38
XRS2.F Xtrackers Russell 2000 UCITS ETF 0.00200245 318.35
SC0K.DE Invesco Russell 2000 UCITS ETF 0.0016 115.64
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00078 166.41
RTYS.L Invesco Russell 2000 UCITS ETF 0.0016 137.58
XRSG.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00200245 29157
XRSU.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00200245 398.72
ZPRR.DE SPDR Russell 2000 US Small Cap UCITS ETF 0.00021 65.97
R2SC.L SPDR Russell 2000 US Small Cap UCITS ETF 0.00021 57.43
XRS2.DE Xtrackers Russell 2000 UCITS ETF 0.00200245 335.2
VTS.AX Vanguard US Total Market Shares Index ETF 0.00009 482.09
VEMPX Vanguard Extended Market Index InstlPlus 0.00078 410.63
ITDG iShares Trust 0 39.4501
ITDI iShares Trust 0 39.4096
ITDH iShares Trust 0 39.45
ITDF iShares Trust 0 38.9027
ITDC iShares Trust 0 35.15
ITDB iShares Trust 0 33.84
ITDD Integrated Data Corp. 0 36.63
ITDE iShares Trust 0 37.7759
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00009 312.11
RSSL Global X Funds 0 104.25
ITDJ iShares Trust 0 30.6464
Unlock